Strides Arcolab Ltd

ISIN: INE939A01011 | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE 681.90 -4.75 [-0.69%]

NSE 681.95 -4.80 [-0.70%]

BSE : May 24, 22:10

Open Price	693.50	Shares Traded	5934
High Price	693.50	52 Wk High	717.30
Low Price	673.00	52 Wk Low	276.25
Previous Close	686.65	Face Value	10.00
52 Wk High Date	-	52 Wk Low Date	-

NSE : May 24, 22:10

Open Price	690.15	Shares Traded	196743
High Price	692.00	52 Wk High	723.80
Low Price	672.10	52 Wk Low	276.00
Previous Close	686.75	Face Value	10.00
52 Wk High Date	-	52 Wk Low Date	-

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
Year End	Mar, 2012	Mar, 2012	Dec, 2011
Sales (Rs.cr)	124.01	706.32	709.51
Net Profit (Rs.cr)	4.46	76.25	70.75
Net Profit Var (%)	-	247.00	128.00
EPS (Rs)	-		11.70
P/E Ratio	-	51.32	57.00
Operating Profit Margin	-	13.65	-
CPS (Rs.)	-	-	14.70
P/C Ratio	-	-	45.20
Div%	-	-	20.00

Related Companies
Stock Name	Price
CIPLA	310.00
JBCHEPHARM	62.70
JAYANTVITAMINS	3.00
MERIND	200.00
PIRHEALTH	424.00
RANBAXY	504.60
UNICHEMLAB	132.00
ALEMBICLTD	15.20
LYKALABS	9.70
TTKHEALTH	358.15

Fundamentals
Market Capital (Rs.cr)	3910.65
EPS (Rs.)(TTM)
P/E Ratio(TTM)	51.32
Book Value (Rs.)	231.70
Price to Book Value	2.88
Equity (Rs.cr.)	58.67
Traded Value (Rs.lac)	546.73

Announcements
11-04-2012	Strides Acrolab received final approval for the Vancomycin Hydrochloride capsules
23-12-2010	Strides Arcolab & Ascent Pharmahealth enters into scheme implementation agreement
11-12-2010	Strides Arcolab announces US FDA approval for Lidocaine Hydrochloride injection 16th sterile in
26-04-2012	Strides acquires USFDA approved Sterile Formulations facility
21-09-2011	Strides Acrolab received final approval for the Vancomycin Hydrochloride injection
01-07-2011	Strides announces European approval for its Oral Dosage Oncology facility
15-09-2011	Strides announces European approval for Oxaliplatin injection
18-11-2010	Strides Arcolab allots equity shares
03-04-2012	Strides Arcolab announces Health Canada approval for Tobramycin Injection
30-12-2010	Strides Arcolab announces sale of product portfolio by Akorn-Strides LLC to Pfizer Inc
28-07-2011	Strides Arcolab announces USFDA approval for Acarbose tablets
09-02-2011	Strides Arcolab grants options
20-10-2011	Strides Arcolab receives approval for Bupivacaine Hydrochloride injections
11-10-2011	Strides Arcolab receives approval for Cladribine Injection
02-11-2011	Strides Arcolab receives approval for Doxorubicin Injection
11-05-2012	Strides Arcolab receives US FDA approval for Acetazolamide Injection
26-07-2011	Strides Arcolab receives USFDA approval for Gemcitabine for injection USP
19-04-2011	Strides Arcolab receives USFDA approval For its new sterile injectable facility
31-03-2012	Strides Arcolab receives USFDA approval for Methotrexate Injection
01-12-2010	Strides Arcolab receives USFDA approval for Midazolam Hydrochloride injection
25-02-2011	Strides Arcolab recommends dividend
24-01-2012	Strides Arcolab sells its generic pharmaceuticals operations in Australia & Southeast Asia to Watson
12-02-2011	Strides Arcolab to announce financial results
11-11-2011	Strides Arcolab to issue warrants

Gross Deliverables
Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
15-05-2012	4459	19772	22.55	2893668	12,957.10
11-05-2012	4956	10231	48.44	3398577	7,031.15
09-05-2012	9417	27309	34.48	6496788	19,029.60
08-05-2012	23945	49464	48.41	16636986	34,337.40
04-05-2012	10488	18847	55.65	7162255	12,824.80

Add Your Website

Tell a Friend